Hologic Inc. (NSDQ:HOLX) agreed to acquire Sentinelle Medical Inc. for $85 million plus contingencies.
The deal calls for Bedford, Mass.-based Hologic to pay a “two-year contingent earn out,” according to a press release, for Toronto-based Sentinelle, which makes MRI breast coils, tables and visualization software.
The earn-out involves cash payments equal to a multiple of the incremental revenue growth in Sentinelle Medical’s business in the two years following the deal’s consummation, according to the release. Hologic said it expects the buyout to close during the third quarter.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Sentinelle posted sales of about $15 million last year. Hologic said the deal expands its reach into the women’s health market “by offering additional products through existing sales channels,” capitalizing on Sentinelle’s high-performance, “best-in-class” MR coils “to expedite new advances in breast imaging,” according to the release.
Hologic, which posted a second-quarter profit of $20.6 million during the three months ended March 27, became the first company to win European certification for a mammography system last month after the European Reference Organization Council for Quality Assured Breast Screening and Diagnostic Services granted its Selenia system a “Mammographic Type Test” certification.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.